A medical device delivery system and method of manufacture that includes an outer catheter, a first inner catheter insertable through the outer catheter, and a second inner catheter insertable through the first inner catheter and adapted to receive a guidewire extending there through. The first inner catheter includes a braided reinforcement layer and is adapted to receive an elongated medical device extending there through.
|
10. A method for manufacturing a medical device delivery system, comprising:
forming an outer catheter;
forming a first inner catheter insertable through the outer catheter and adapted to receive an elongated medical device extending therethrough wherein forming the first inner catheter includes forming a braided reinforcement layer including a first wire braided in tow with a second wire in a first braiding direction and a third wire braided in tow with a fourth wire in a second braiding direction; and
forming a second inner catheter insertable through the first inner catheter adapted to receive a guidewire extending therethrough.
1. A medical device delivery system, comprising:
an outer catheter;
a first inner catheter insertable through the outer catheter, the first inner catheter adapted to receive an elongated medical device extending therethrough;
a braided reinforcement layer positioned within the first inner catheter that includes a plurality of wires, wherein a first wire of the plurality of wires is braided in tow with a second wire of the plurality of wires in a first braiding direction, and a third wire of the plurality of wires is braided in tow with a fourth wire of the plurality of wires in a second braiding direction, the braided reinforcement layer having a length extending over the length of the first inner catheter; and
a second inner catheter insertable through the first inner catheter and adapted to receive a guidewire extending therethrough.
2. The system of
3. The system of
4. The system of
5. The system of
6. The system of
7. The system of
8. The system of
9. The system of
11. The method of
13. The method of
14. The method of
15. The method of
16. The method of
17. The method of
18. The method of
19. The method of
|
The invention relates generally to implantable medical devices and, in particular, to a transvenous delivery system for elongated medical devices.
Transvenous endocardial leads may be placed inside a chamber of a patient's heart by passing the lead through a venous entry site, such as the subclavian vein or the cephalic vein, or a tributary thereof, along a venous pathway into the superior vena cava and into the right cardiac chambers. Cardiac vein leads may be advanced further, from the right atrium through the coronary sinus ostium into the coronary sinus and ultimately into one of the various cardiac veins for stimulation and/or sensing of the left heart chambers.
Cardiac lead placement is important in achieving accurate sensing of cardiac signals and proper cardiac stimulation pulse delivery for providing optimal therapeutic benefit from cardiac stimulation therapies such as cardiac resynchronization therapy (CRT). Cardiac vein leads generally need to be small in diameter to allow advancement through the cardiac veins and highly flexible in order to withstand flexing motion caused by the beating heart without fracturing. The small diameter and flexibility of the lead, however, makes advancement of the lead along a tortuous venous pathway challenging. Cardiac vein leads are generally implanted with the aid of a relatively stiff guide catheter and/or guidewire or stylet. Considerable skill and time are required to achieve proper placement of a transvenous lead along a cardiac vein site.
A subselection catheter is a catheter that is relatively smaller in diameter and more flexible than the guide catheter and is used for selecting a cardiac vein branch in which the lead will ultimately be implanted. The guide catheter is typically advanced to the os of the coronary sinus. The subselection catheter is advanced through the guide catheter into the coronary sinus and further into a selected cardiac vein branch with the use of a guidewire. When the targeted implant site is reached, the subselection catheter is removed, and the cardiac vein lead is advanced over the guidewire to the targeted implant site. The guidewire, being very flexible and having a small diameter, sometimes prolapses out of the selected vein branch, back into a larger vessel before the lead is successfully positioned at the targeted implant site. The guidewire then needs to be repositioned, with the use of the subselection catheter. Such occurrences increase the time and difficulty of the implant procedure. Improved transvenous lead delivery systems are needed for facilitating implantation of cardiac leads, particularly for implantation in cardiac vein locations.
In the following description, references are made to illustrative embodiments for carrying out the invention. It is understood that other embodiments may be utilized without departing from the scope of the invention. For purposes of clarity, the same reference numbers are used in the drawings to identify similar elements. Unless otherwise noted, drawing elements are not drawn to scale.
In one embodiment, the invention is directed to a medical device delivery system used for implanting transvenous cardiac leads in the cardiac venous system, referred to generally as “cardiac vein leads.” However, it is recognized that a medical device delivery system provided in accordance with the present invention may be used to deliver other transvenous medical devices, including, for example, fluid delivery devices, diagnostic devices, or sensors.
In forming first inner catheter 14 with a lumen large enough to pass an elongated medical device, first inner catheter 14 has a lumen too large too closely track a guidewire. As such, second inner catheter 16 is provided to closely track guidewire 18 and provide support to first inner catheter 14 during advancement and rotation.
Second inner catheter 16 is adapted for receiving a guidewire 18 extending there through. Second inner catheter 16 is provided as a flexible, relatively thin-walled sheath for easily tracking guidewire 18. Second inner catheter 16 is arranged telescopically with first inner catheter 14 and outer catheter 12. Second inner catheter 16 is maneuvered in a telescopic manner with first inner catheter 14 until first inner catheter 14 is positioned at a targeted implant or therapy delivery site. For example, during a cardiac vein lead implant procedure, outer catheter 12 is advanced to the os of the coronary sinus. The first and second inner catheters 14 and 16 are advanced into the coronary sinus and, with the use of guidewire 18, advanced in a telescoping manner to sub-select a desired cardiac vein branch. In an alternative embodiment, second inner catheter 16 may be provided as a solid member for supporting first inner catheter 14 and advance in a telescoping manner with first inner catheter 14 to subselect a desired cardiac vein.
Second inner catheter 14 may be provided with a variable durometer having a relatively stiff portion extending from the proximal end, a soft distal portion, and a radio-opaque distal tip. Second inner catheter 14 is typically provided without a reinforcing layer.
The inner diameter and outer diameter design requirements imposed on first inner catheter 14 for serving as both a sub-selection catheter and a medical device delivery catheter require first inner catheter 14 to be provided with a relatively thin wall. A thin wall also allows first inner catheter 14 to possess lateral or bending flexibility needed to follow a tortuous venous pathway to a targeted cardiac vein branch.
However, first inner catheter 14 is required to possess adequate torsional rigidity to transfer rotational motion between the proximal catheter end and the distal catheter end being advanced to an implant site. First inner catheter 14 includes a reinforcing layer 24, on or in the first inner catheter wall 25, in order to provide an outer diameter small enough to pass through cardiac vein branches, an inner diameter large enough to allow passage of an elongated medical device, and adequate torsional rigidity to allow rotation of the distal catheter end 22 in response to rotation of the proximal catheter end.
In the example shown eight pairs of wires 31a through 31h are braided in the first braiding direction 38 with eight pairs of wires 33a through 33h braided in the second braiding direction to provide a braided reinforcing layer 24a composed of thirty two wires. Any number of pairs of wires may be braided to from braided reinforcement layer 24 using a braiding machine, such as those commercially available from Steeger, Germany; Wardwel, Mass., or other commercial suppliers. Furthermore, it is recognized that three or more wires may be braided in tow in triplets, quadruplets, etc. By providing multiple wires braided in the “in-tow” manner as shown, the torsional rigidy of first inner catheter 14 is improved, allowing first inner catheter 14 to be manufactured with a thin wall, maneuverable through small cardiac veins and allowing passage of an elongated medical device through first inner catheter 14.
Wires 30a, 32a, 34a, and 36a are typically formed from stainless steel, a shape memory alloy such as Nitinol®, a polymeric fiber such as polyethylene napthalate, or other material that can be formed into a small cross-sectional wire having sufficient tensile strength to undergo the braiding process. The wires 30a, 32a, 34a, and 36a may be provided with a generally round or flat cross-sectional geometry. First inner catheter 14 is provided as a slittable catheter for removing catheter 14 over an implanted medical device. By forming reinforcing layer 24 using a braided polymer wire such as polyethylene napthalate, forces required to slit the catheter body are reduced, making it easier to remove catheter 14 from the implanted medical device without dislodging the medical device from the implant site.
Braided reinforcing layer 24 is formed over the outer surface of the inner tubular member 40. The braid density or “pic count” may be constant or variable and will be selected to provide the desired lateral flexibility, torsional rigidity, kink resistance, and pushability needed for a particular application. The pic count will typically range from 20 to 150 pics/inch and will usually fall in the range of approximately 45-60 pics/inch. An outer tubular member 42 is formed over braided reinforcing layer 24. Outer tubular member 42 is typically formed of a soft thermoplastic material such as a polyamide polyether block polymer, polyurethanes, silicone rubbers, nylons, polyethylenes, or fluoronated hydrocarbon polymers.
First inner catheter 14 may be provided having variable mechanical properties along the length of the catheter shaft 44. For example, catheter shaft 44 may be provided with three distinct regions as generally disclosed in U.S. Pat. No. 5,676,659 (McGurk), hereby incorporated herein by reference in its entirety. A first region extending from the proximal end of first inner catheter 14 includes outer tubular member 42, reinforcing layer 24 and inner tubular member 40. A second region extends from the termination of reinforcing layer 24 and includes inner and outer tubular members 40 and 42. The second region serves as a transition region between the first region and a third region including only outer tubular member 42. Outer tubular member 42 is formed to provide a continuous inner diameter with the inner tubular member 40 to thereby provide a constant diameter medical device delivery lumen. First inner catheter 14 may be provided with a distal end formed of a radio-opaque material.
The reinforcing layer formed along proximal region 52 is provided with a low pic count, which results in a relatively more axial orientation of the wires forming the reinforcing layer giving proximal region 52 enhanced pushability. The pic count is gradually transitioned from a lower pic count to a higher pic count along transition region 54. Distal region 56 is provided with a higher pic count than proximal region 52, giving distal region 56 enhanced flexibility. It is recognized that multiple regions may be formed having varying pic counts to provide shaft 44 with desired variation in mechanical properties.
In some embodiments, first inner catheter 14 may additionally include a second pre-shaped portion 50 along first inner catheter shaft 44, proximal to the distal pre-shaped portion 48. Proximal pre-shaped portion 50 may be provided as a generally “C-shaped” curve or other pre-shaped bend, curve, or angle. Proximal pre-shaped portion 50 is formed for providing cardiac vein wall support when tracking into a cardiac vein branch.
Thus, a medical device delivery system has been presented in the foregoing description with reference to specific embodiments. It is appreciated that various modifications to the referenced embodiments may be made without departing from the scope of the invention as set forth in the following claims.
Schneider, Mark D., Shah, Sonar, Raze, Brian
Patent | Priority | Assignee | Title |
10926077, | May 11 2016 | Nunzio P., Pagano, II; Peter L., Pagano | Interchangeable lockable catheter |
9764139, | Jan 24 2014 | Medtronic, Inc. | Pre-implant detection |
Patent | Priority | Assignee | Title |
3485234, | |||
4243050, | Dec 13 1977 | LITTLEFORD,ELIZABETH H | Method for inserting pacemaker electrodes and the like |
5120323, | Jan 12 1990 | SciMed Life Systems, INC; Boston Scientific Scimed, Inc | Telescoping guide catheter system |
5964795, | Mar 13 1998 | Medtronic, Inc.; Medtronic, Inc | Medical electrical lead |
6022336, | May 20 1996 | MIRAGE IP LLC | Catheter system for emboli containment |
6059779, | Apr 28 1995 | STRYKER EUROPEAN HOLDINGS III, LLC | Delivery catheter for electrolytically detachable implant |
6540733, | Dec 29 2000 | CARDINAL HEALTH SWITZERLAND 515 GMBH | Proton generating catheters and methods for their use in enhancing fluid flow through a vascular site occupied by a calcified vascular occlusion |
6709429, | Jan 19 2000 | Boston Scientific Scimed, Inc | Intravascular catheter with multiple axial fibers |
6733500, | Mar 31 2000 | Medtronic, Inc | Method and system for delivering a medical electrical lead within a venous system |
6755812, | Dec 11 2001 | Cardiac Pacemakers, Inc | Deflectable telescoping guide catheter |
6836687, | Mar 31 2000 | Medtronic, Inc | Method and system for delivery of a medical electrical lead within a venous system |
6871085, | Sep 30 2002 | Medtronic, Inc | Cardiac vein lead and guide catheter |
7297302, | Aug 18 1993 | Boston Scientific Scimed, Inc | Catheter having a high tensile strength braid wire constraint and method of manufacture |
7438712, | Mar 05 2003 | LifeShield Sciences LLC | Multi-braid exterior tube |
20030130598, | |||
20030144657, | |||
20030208141, | |||
20040019359, | |||
20040153049, | |||
20040215139, | |||
20050004553, | |||
20050020914, | |||
WO2005007228, | |||
WO20050002658, |
Executed on | Assignor | Assignee | Conveyance | Frame | Reel | Doc |
Apr 20 2006 | SCHNEIDER, MARK D | Medtronic, Inc | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 018928 | /0144 | |
Apr 21 2006 | RAZE, BRIAN | Medtronic, Inc | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 018928 | /0144 | |
Apr 27 2006 | Medtronic, Inc. | (assignment on the face of the patent) | / | |||
May 16 2006 | SHAH, SONAR | Medtronic, Inc | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 018928 | /0144 |
Date | Maintenance Fee Events |
Feb 22 2011 | ASPN: Payor Number Assigned. |
Sep 08 2014 | M1551: Payment of Maintenance Fee, 4th Year, Large Entity. |
Aug 21 2018 | M1552: Payment of Maintenance Fee, 8th Year, Large Entity. |
Aug 19 2022 | M1553: Payment of Maintenance Fee, 12th Year, Large Entity. |
Date | Maintenance Schedule |
Mar 08 2014 | 4 years fee payment window open |
Sep 08 2014 | 6 months grace period start (w surcharge) |
Mar 08 2015 | patent expiry (for year 4) |
Mar 08 2017 | 2 years to revive unintentionally abandoned end. (for year 4) |
Mar 08 2018 | 8 years fee payment window open |
Sep 08 2018 | 6 months grace period start (w surcharge) |
Mar 08 2019 | patent expiry (for year 8) |
Mar 08 2021 | 2 years to revive unintentionally abandoned end. (for year 8) |
Mar 08 2022 | 12 years fee payment window open |
Sep 08 2022 | 6 months grace period start (w surcharge) |
Mar 08 2023 | patent expiry (for year 12) |
Mar 08 2025 | 2 years to revive unintentionally abandoned end. (for year 12) |